Volume 85, Issue 6, Pages (June 2014)

Slides:



Advertisements
Similar presentations
Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.
Advertisements

Evaluation and treatment of coronary artery disease in patients with end-stage renal disease Peter A. McCullough Kidney International Volume 67, Pages.
MariLia Bahiense Oliveira, Joao Egidio Romao, Roberto Zatz 
Anemia management in chronic kidney disease
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease  Kevin E. Chan, Ravi I. Thadhani,
Volume 83, Issue 3, Pages (March 2013)
Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure  Steven Fishbane, Nobuyuki Miyawaki  Kidney International 
Kidney transplantation in a low-resource setting: Nigeria experience
Continuous renal replacement therapy in the critically ill patient
Reassessment of the care of the patient with chronic kidney disease
John P. Middleton, Patrick H. Pun  Kidney International 
Volume 77, Issue 1, Pages 6-8 (January 2010)
Burden of chronic kidney disease: North Africa
Francesco Paolo Schena  Kidney International 
Need for better diabetes treatment for improved renal outcome
Jeffrey C. Fink, Glenn M. Chertow  Kidney International 
End-stage renal disease in living kidney donors
Comorbidity and confounding in end-stage renal disease
Acute myocardial infarction in patients with chronic kidney disease: how are the most vulnerable patients doing?  Gautam R. Shroff, Charles A. Herzog 
Volume 74, Issue 3, Pages (August 2008)
Volume 70, Issue 11, Pages (December 2006)
Volume 87, Issue 2, Pages (February 2015)
Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.
Volume 71, Issue 6, Pages (March 2007)
Volume 70, Issue 12, Pages (December 2006)
Fructose intake as a risk factor for kidney stone disease
Response to ‘Hepcidin levels in patients with renal disease’
Volume 73, Issue 12, Pages (June 2008)
Volume 76, Issue 6, Pages (September 2009)
Volume 87, Issue 1, Pages (January 2015)
New insights in uremic toxins
Extracorporeal therapy in sepsis: are we there yet?
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Tilman B. Drüeke, Ziad A. Massy  Kidney International 
Elevated risk of stroke among patients with end-stage renal disease
Alternate-day dialysis may be needed for hemodialysis patients
Nephrology Crossword: Peritoneal Dialysis
Volume 87, Issue 1, Pages (January 2015)
Racial disparities in access to transplantation: a tough nut to crack
Atrial fibrillation in end-stage renal disease: an emerging problem
Starting dialysis is dangerous: how do we balance the risk?
Nephrology Crossword: Glomerulonephritis
A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease  S. Susan Hedayati, Venkata Yalamanchili,
Unilateral renal cystic disease
Volume 85, Issue 5, Pages (May 2014)
Volume 81, Issue 9, Pages (May 2012)
A man with a hole in his penis
Prehypertension: is it relevant for nephrologists?
Homocysteine, renal function, and risk of cardiovascular disease
Volume 73, Issue 9, Pages (May 2008)
Volume 81, Issue 12, Pages (June 2012)
Volume 72, Issue 2, Pages (July 2007)
Volume 55, Pages S3-S16 (June 1999)
The Danish Renal Biopsy Register
Volume 80, Issue 10, Pages (November 2011)
Is complement a target for therapy in renal disease?
Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate  S. Aime, C. Canavese, P. Stratta  Kidney International 
Renal prognosis of toxigenic Escherichia coli infection
Volume 75, Issue 7, Pages (April 2009)
Changes to the End-Stage Renal Disease Quality Incentive Program
James B. Young, Hans-Hellmut Neumayer, Robert D. Gordon 
The international realities of live donor kidney transplantation
Volume 70, Issue 10, Pages (November 2006)
Asymmetric dimethylarginine: A cardiovascular risk factor in renal disease?  Danilo Fliser, Jan T. Kielstein, Hermann Haller, Stefanie M. Bode-Böger  Kidney.
The Ebf1 knockout mouse and glomerular maturation
Sugar-sweetened beverages and chronic disease
Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies  Lei-Shi Li, Zhi-Hong Liu  Kidney International 
Dhanya Mohan, Mohammed Railey
Presentation transcript:

Volume 85, Issue 6, Pages 1275-1282 (June 2014) Epidemiology, impact, and treatment options of restless legs syndrome in end-stage renal disease patients: an evidence-based review  Christoforos D. Giannaki, Georgios M. Hadjigeorgiou, Christina Karatzaferi, Marios C. Pantzaris, Ioannis Stefanidis, Giorgos K. Sakkas  Kidney International  Volume 85, Issue 6, Pages 1275-1282 (June 2014) DOI: 10.1038/ki.2013.394 Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 1 The effect of uremic restless legs syndrome (RLS) on overall health and quality-of-life parameters. Kidney International 2014 85, 1275-1282DOI: (10.1038/ki.2013.394) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 2 Factors that may contribute to an increased cardiovascular risk in patients with uremic restless legs syndrome (RLS). Kidney International 2014 85, 1275-1282DOI: (10.1038/ki.2013.394) Copyright © 2014 International Society of Nephrology Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.